CIK 0001579428 · Large accelerated filer
Axsome Therapeutics, Inc.
Sign in to watch- Ticker
- AXSM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 454241907
- Phone
- (212) 332-3241
- Business address
- ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK, NY, 10007
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,086,500
- in 1 filing, $2.1M under 10b5-1 plans
Net −$2,086,500. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-26 | Jacobson Mark L. Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −35,378 | 0 | ||
| 2026-02-23 | Coleman Mark Director | Option exercise | +6,250 | $4.95 | $31K | 72,140 |
| 2026-02-23 | Coleman Mark Director | Option exercise · Stock Option (Right to Buy) | −6,250 | 7,721 | ||
| 2026-02-20 | Coleman Mark Director | Option exercise | +12,485 | $4.95 | $62K | 65,890 |
| 2026-02-20 | Coleman Mark Director | Option exercise · Stock Option (Right to Buy) | −12,485 | 13,971 | ||
| 2026-02-10 | Coleman Mark Director | Option exercise | +5,193 | $8.02 | $42K | 53,405 |
| 2026-02-10 | Coleman Mark Director | Option exercise · Stock Option (Right to Buy) | −5,193 | 0 | ||
| 2026-02-02 | TABUTEAU HERRIOT Chief Executive Officer | Option exercise 10b5-1 | +32,410 | $8.02 | $260K | 39,639 |
| 2026-02-02 | TABUTEAU HERRIOT Chief Executive Officer | Sale 10b5-1 | −32,410 | $185.60 | $6.0M | 7,229 |
| 2026-02-02 | TABUTEAU HERRIOT Chief Executive Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −32,410 | 0 | ||
| 2026-01-22 | Pizzie Nick Chief Financial Officer | Option exercise 10b5-1 | +12,000 | $3.50 | $42K | 54,588 |
| 2026-01-22 | Pizzie Nick Chief Financial Officer | Sale 10b5-1 | −12,000 | $187.92 | $2.3M | 42,588 |
| 2026-01-22 | Pizzie Nick Chief Financial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −12,000 | 105,000 | ||
| 2026-01-21 | Maizel Ari Chief Commercial Officer | Option exercise 10b5-1 | +7,500 | $70.73 | $530K | 7,500 |
| 2026-01-21 | Maizel Ari Chief Commercial Officer | Sale 10b5-1 | −7,500 | $184.44 | $1.4M | 0 |
| 2026-01-21 | Maizel Ari Chief Commercial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −7,500 | 31,210 | ||
| 2026-01-07 | TABUTEAU HERRIOT Chief Executive Officer | Option exercise 10b5-1 | +31,261 | $8.02 | $251K | 38,490 |
| 2026-01-07 | TABUTEAU HERRIOT Chief Executive Officer | Sale 10b5-1 | −31,261 | $170.38 | $5.3M | 7,229 |
| 2026-01-07 | TABUTEAU HERRIOT Chief Executive Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −31,261 | 32,410 | ||
| 2026-01-06 | TABUTEAU HERRIOT Chief Executive Officer | Option exercise 10b5-1 | +29,450 | $8.02 | $236K | 36,679 |
Page 4 of 22 · 422 trades